Evaluation of Hyoscine butylbromide effects on pain severity of first stage of labor and fetal heart rate in multiparous women

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180424039407N1

Enrollment

100

Registered

2018-07-04

Start date

2018-05-22

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delivery. Encounter for full-term uncomplicated delivery

Interventions

Intervention 1: Intervention group: Receiving 20 mg Hyoscine (1 ml) intravenously during the active phase of labor. Intervention 2: Control group: Receiving 1 ml normal saline intravenously during the

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Age of 18-35 Singleton pregnancy Not having pregnancy complications such as gestational diabetes Gestational age of 37-42 weeks

Exclusion criteria

Exclusion criteria: Cardiovascular disease Hypo- or hyperthyroidism Preeclampsia

Design outcomes

Primary

Measure	Time frame
Pain severity of first stage of labor. Timepoint: During the first stage of labor. Method of measurement: By using Visual Analog Scale (VAS).;Fetal Heart Rate. Timepoint: During the full labor time. Method of measurement: By using a sonicaid device.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfra Pazhouhi

Zahedan University of Medical Sciences

Afrapazhouhi@gmail.com+98 54 3329 5715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026